Live Breaking News & Updates on Wildon Farwell

Stay updated with breaking news from Wildon farwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dyne Therapeutics (NASDAQ:DYN) PT Raised to $42.00

Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price target boosted by Jefferies Financial Group from $36.00 to $42.00 in a research note released on Monday, Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. DYN has been the topic of several other research reports. Morgan Stanley assumed coverage on Dyne […] ....

United States , Oxana Beskrovnaya , Wildon Farwell , Piper Sandler , Zurcher Kantonalbank Zurich Cantonalbank , Stifel Nicolaus , Jefferies Financial Group , Allspring Global Investments Holdings , Dyne Therapeutics Inc , Morgan Stanley , Securities Exchange Commission , China Universal Asset Management Co , Dyne Therapeutics Company Profile , Principal Financial Group Inc , Wetzel Investment Advisors Inc , Dyne Therapeutics , Free Report , Financial Group , Chardan Capital , Moderate Buy , Therapeutics Trading Down , Get Free Report , Exchange Commission , Investment Advisors , Kantonalbank Zurich Cantonalbank , Global Investments Holdings ,

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints

- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - - DYNE-101 Showed Improvement in Myotonia,. ....

United States , Stacy Nartker , Wildon Farwell , Amy Reilly , John Cox , Exchange Commission , Drug Administration , Myotonic Dystrophy Health Index , European Medicines Agency , Dyne Therapeutics Inc , Dose Dependent , Mean Splicing Correction Across All Patients , Muscle Strength , Timed Function Tests , Reported Outcomes , Mean Unadjusted , Mean Muscle Adjusted , Dystrophin Expression , Cohort Administered Monthly , Higher Level , Dystrophin Than Reported , Weekly Administered Standard , Functional Improvement , Run Time , Stride Velocity , Safety Profiles ,

Dyne Therapeutics Announces New Clinical Data from ACHIEVE

- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - . ....

United States , Amy Reilly , John Cox , Stacy Nartker , Wildon Farwell , Exchange Commission , Dyne Therapeutics Inc , European Medicines Agency , Drug Administration , Myotonic Dystrophy Health Index , Dose Dependent , Mean Splicing Correction Across All Patients , Muscle Strength , Timed Function Tests , Reported Outcomes , Mean Unadjusted , Mean Muscle Adjusted , Dystrophin Expression , Cohort Administered Monthly , Higher Level , Dystrophin Than Reported , Weekly Administered Standard , Functional Improvement , Run Time , Stride Velocity , Safety Profiles ,

Dyne Therapeutics (NASDAQ:DYN) Trading Down 3.2%

Dyne Therapeutics (NASDAQ:DYN) Trading Down 3.2%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Stifel Nicolaus , Piper Sandler , Richard William Scalzo , Wildon Farwell , Dyne Therapeutics Company Profile , Morgan Stanley , Dyne Therapeutics Inc , Securities Exchange Commission , Janus Henderson Group , First Light Asset Management , Pricet Rowe Associates Inc , Dyne Therapeutics , Get Free Report , Therapeutics Stock Down , William Scalzo , Exchange Commission , State Teachers Retirement System , Henderson Group , Light Asset Management , Pricet Rowe Associates , Dyne Therapeutics Daily ,

Chardan Capital Reaffirms "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN)

Chardan Capital Reaffirms "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Wildon Farwell , Jasonp Rhodes , Piper Sandler , Stifel Nicolaus , Acuta Capital Partners , Td Asset Management Inc , Profund Advisors , Dyne Therapeutics Inc , Hermes Inc , Morgan Stanley , Securities Exchange Commission , Chardan Capital , Dyne Therapeutics , Free Report , Dyne Therapeutic , Moderate Buy , Get Free Report , Exchange Commission , Director Jason , Capital Partners , Management Inc , Dyne Therapeutics Daily ,